日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

LDI, A Lipid Droplet Inhibitor, Disrupts Lipid Accumulation and Modulates Hepatic Lipid Profiles in Fatty Liver.

LDI(一种脂滴抑制剂)可破坏脂质积累并调节脂肪肝中的肝脏脂质谱。

Kim Seunghee, Kim Yeojin, Paudel Sanjita, Kang In Young, Kim Suyeon, Kim Jeesoo, Park Sunmi, Koo Seung-Hoi, Kim Hyun Sung, Jun Dae Won, Park Jinyoung, Lee Hyunbeom, Lee Joonseok

Normal-weight metabolic dysfunction-associated steatotic liver disease: reclassification, characteristics, and adverse liver outcomes across diverse populations

正常体重代谢功能障碍相关脂肪肝疾病:不同人群的重新分类、特征和不良肝脏结局

Song, Sherlot Juan; Yoon, Eileen Laureal; Wong, Vincent Wai-Sun; Jo, Ae Jeong; Wong, Grace Lai-Hung; Lai, Jimmy Che-To; Jun, Dae Won; Yip, Terry Cheuk-Fung

Evaluating treatment response thresholds for cost-effective treatment in metabolic dysfunction-associated steatotic liver disease

评估代谢功能障碍相关脂肪肝疾病的成本效益治疗反应阈值

Yoon, Eileen L; Cho, Jeong-Yeon; Park, Huiyul; Kim, Mimi; Park, Ji-Hyeon; Kim, Hye-Lin; Jun, Dae Won

The MASLD Journey in the General Population: Linkage-to-Care and Patient-Reported Uptake of Fibrosis Risk Assessment

普通人群中的MASLD诊疗历程:与医疗服务的衔接及患者报告的纤维化风险评估接受情况

Oh, Joo Hyun; Lee, Jun-Hyuk; Ahn, Sang Bong; Kwon, Eunjoo; Yoon, Eileen L; Lee, Hyo Young; Cho, Seon; Jun, Dae Won

Correction to: Misclassification of Alcohol Use Disorder in MASLD and MetALD: Prevalence, Clinical Characteristics, and Outcomes

更正:MASLD 和 MetALD 中酒精使用障碍的误诊:患病率、临床特征和结果

Lee, Jun-Hyuk; Ahn, Sung-Ho; Park, Jimin; Jeon, So Young; Yoon, Eileen L; Lee, Hye Sun; Jun, Dae Won

Age serves as the silent architect of FIB-4's precision in unveiling advanced hepatic fibrosis in MASLD with T2DM: Correspondence to letter to the editor on "Diagnostic accuracy of the fibrosis-4 index for advanced liver fibrosis in nonalcoholic fatty liver disease with type 2 diabetes: a systematic review and meta-analysis"

年龄是 FIB-4 在揭示伴有 2 型糖尿病的非酒精性脂肪性肝病 (MASLD) 中晚期肝纤维化方面发挥精准作用的幕后推手:对“纤维化-4 指数诊断伴有 2 型糖尿病的非酒精性脂肪性肝病晚期肝纤维化的准确性:系统评价和荟萃分析”一文的读者来信

Han, Ji Won; Jun, Dae Won

Correspondence to editorial on "Prevalence of clinically significant liver fibrosis in the general population: A systematic review and meta-analysis"

致编辑的信函,主题为“普通人群中具有临床意义的肝纤维化的患病率:系统评价和荟萃分析”

Kim, Hee Yeon; Choi, Miyoung; Jun, Dae Won

Correspondence to letter to the editor on "Prevalence of clinically significant liver fibrosis in the general population: A systematic review and meta-analysis"

致编辑的信函,主题为“普通人群中具有临床意义的肝纤维化的患病率:系统评价和荟萃分析”

Kim, Hee Yeon; Choi, Miyoung; Jun, Dae Won

Solving care labor shortages through employee-driven experiments: A multiple case study

通过员工主导的实验解决护理人员短缺问题:一项多案例研究

Jin, Young-Joo; Kim, Hee Yeon; Suh, Young Ju; Lee, Chae Hyeon; Yu, Jung Hwan; Kim, Mi Na; Han, Ji Won; Lee, Han Ah; An, Jihyun; Chon, Young Eun; Jun, Dae Won; Choi, Miyoung; Kim, Seung Up; Weiste, E; Saari, E; Lappalainen, K; Koivisto, T

Impacts of metabolic syndrome diseases on long-term outcomes of chronic hepatitis B patients treated with nucleos(t)ide analogues

代谢综合征疾病对接受核苷(酸)类似物治疗的慢性乙型肝炎患者长期预后的影响

Huang, Rui; Jun, Dae Won; Toyoda, Hidenori; Hsu, Yao-Chun; Trinh, Huy; Nozaki, Akito; Ishikawa, Toru; Watanabe, Tsunamasa; Uojima, Haruki; Huang, Daniel Q; Honda, Takashi; Tanaka, Yasuhito; Vutien, Philip; Marciano, Sebastián; Abe, Hiroshi; Enomoto, Masaru; Atsukawa, Masanori; Takahashi, Hirokazu; Tsuji, Kunihiko; Takaguchi, Koichi; Tsai, Pei-Chien; Dai, Chia-Yen; Huang, Jee-Fu; Huang, Chung-Feng; Yeh, Ming-Lun; Yoon, Eileen; Kim, Sung Eun; Ahn, Sang Bong; Kim, Gi-Ae; Jung, Jang Han; Jeong, Soung Won; Oh, Hyunwoo; Tseng, Cheng-Hao; Ishigami, Masatoshi; Chau, Angela; Maeda, Mayumi; Yasuda, Satoshi; Chuma, Makoto; Ito, Takanori; Kawashima, Keigo; Liu, Joanne Kimiko; Gadano, Adrian; Kozuka, Ritsuzo; Itokawa, Norio; Inoue, Kaori; Senoh, Tomonori; Li, Jie; Chuang, Wan-Long; Cheung, Ramsey; Wu, Chao; Yu, Ming-Lung; Nguyen, Mindie H